Diego Arango del Corro

AREA BME/ Biomedicine SUB AREA CAN/ Cancer KEYWORDS MOLECULAR ONCOLOGY, COLORECTAL CANCER, GENETICS, CLINICAL TRIALS, MOUSE MODELS, PATIENTS, THERAPIES, REGORAFENIB, TAS102, PREDICTIVE BIOMARKER SIGNATURES, CLINICAL IMPLEMENTATION, MICRORNA PREDICTORS SUPERVISORY TEAM DR. DIEGO ARANGO DEL CORRO Supervisor Dr. Diego Arango is the current director of the Lleida Biomedical Research Institute (IRBLLeida). He leads a well consolidated…